Latent Health is building intelligence infrastructure for American healthcare, with a particular focus on streamlining specialty medication approvals. Founded in 2023 and backed by $80 million in Series A funding, the company operates at the intersection of clinical AI, agentic engines, data ingestion, and workflow automation.
The company's core product, the Enterprise Pharmacy Intelligence Platform, uses a clinical agentic engine to connect providers, insurers, and pharmaceutical companies. It ingests data from sources such as doctor's notes, lab results, and clinical documents to surface patient evidence and automate prior-authorization workflows. The system is designed to reduce the time from prescription to patient care from days to minutes.
Latent Health reports more than 50 health systems as customers, with a specialty fill capture rate of 85% and a 109% increase in prior-authorization throughput per team member. The company estimates its platform avoids over $300,000 in annual labour costs per health system. The company's geographic presence is focused on the United States, serving the healthcare, pharmacy, and insurance sectors.
